Navigation Links
MiMedx Group Announces Second Quarter 2011 Results
Date:7/25/2011

production capabilities to meet the anticipated demand for its initial CollaFix™ products, that the anticipated demand for the Company's CollaFix™ products does not materialize; that the Company may not complete its operational consolidations by the end of the third quarter; and the risk factors detailed from time to time in the Company's periodic Securities and Exchange Commission filings, including, without limitation, its 10-K filing for the fiscal year ended December 31, 2010, and its most recent Form 10-Q. By making these forward-looking statements, the Company does not undertake to update them in any manner except as may be required by the Company's disclosure obligations in filings it makes with the Securities and Exchange Commission under the federal securities laws. MIMEDX GROUP, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)Three Months Ended June 30,Six Months Ended June 30,2011201020112010REVENUES:Net sales

$
,929,399$
322,075$
2,972,886$
436,930OPERATING COSTS AND EXPENSES:Cost of products sold

789,405435,9251,448,281815,513Research and development expenses

662,487752,7111,510,3901,325,115Selling, General and Administrative expenses

2,893,9421,831,2365,686,9983,542,674LOSS FROM OPERATIONS

(2,416,435)(2,697,797)(5,672,783)(5,246,372)OTHER INCOME (EXPENSE), netInterest (expense) income, net

(87,070)1,228(178,284)(592,282)LOSS BEFORE INCOME TAXES

(2,503,505)(2,696,569)(5,851,067)(5,838,654)Income taxes

----NET LOSS

$
(2,503,505)$
(2,696,569)$
(5,851,067)$
(5,838,654)Net loss per common shareBasic and diluted

$
(0.03)$
(0.04)$
(0.08)$
(0.10)Shares used in computing net loss per common shareBasic and diluted

71,819,01760,635,87771,098,97655,918,851MIMEDX GROUP, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETSASSETSJune 30,2011December 31,(unaudited)2010Current assets:Cash and cash equivalent
'/>"/>

SOURCE MiMedx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. MiMedx Group, Inc. Announces Release Date for Second Quarter Results
2. MiMedx Group Completes $5,000,000 Private Placement
3. MiMedx Group, Inc. to Present at the Noble Financial Capital Markets Seventh Annual Equity Conference
4. MiMedx Group Announces First Quarter 2011 Results
5. MiMedx Group Announces 2010 Results
6. MiMedx Group, Inc. to Present at the 10th Annual Needham Healthcare Conference
7. MiMedx Announces Launch of AmnioFix™
8. MiMedx to Attend American Academy of Orthopedic Surgeons Annual Meeting
9. MiMedx Group, Inc. to Present at the 13th Annual Needham Growth Conference
10. MiMedx Group, Inc. Announces Release Date For Third Quarter Results
11. MiMedx Group, Inc. to Present at Noble Financial Sixth Annual Equity Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Sept. 30, 2014 Report Details ... highest potential revenues Do you want to find ... you revenue predictions for those biological drugs from ... you find financial data, R&D trends, opportunities and ... sales forecasts to 2024 at overall world market, ...
(Date:9/30/2014)... Over the last decade, the laboratory filtration market is ... increased acceptance of new filtration technologies in end users ... also catalyzing the growth of laboratory filtration market. , ... at a strong CAGR during the forecast period of ... by 2019. The market is mainly driven by the ...
(Date:9/30/2014)...  RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) ("the Company" ... a Canadian Patent for Inhibition or Reversal of ... claims using thymosin beta 4, various fragments and ... purposes.  The patent will expire in 2021. ... ) RegeneRx is focused on ...
(Date:9/30/2014)... Switzerland (PRWEB) September 30, 2014 ... software solutions for drug discovery and related ... FUNGITECT consortium has chosen Genedata Selector as ... sequencing (NGS) data. FUNGITECT is a European ... invasive fungal diseases via individualized anti-fungal drug ...
Breaking Biology Technology:Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 4Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 5Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 2Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 3Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 4Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 5RegeneRx Receives Canadian Patent for Inhibition or Reversal of Skin Aging 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3
... on its technology strengths, will its economic weaknesses eventually ... 21st century knowledge economy are impressive when compared with ... intimidating, especially when it comes to training and retaining ... skilled workers - from construction trades to laboratory technicians ...
... The past is a source of knowledge, and the future is ... S. Ambrose (1936-2002) Ernest Mueller , ... collections represent,a rich source of study material, much of it meticulously ... the field. While the majority of,this material was originally collected and ...
... , , ... NBS microbiologists recently assisted researchers at the University of ... strain of Pichia pastoris yeast. Top,yields by the researchers thus far ... in shake flasks. By switching to a BioFlo 3000 ...
Cached Biology Technology:To be a player in the "Knowledge Economy," Wisconsin needs more tech workers 2To be a player in the "Knowledge Economy," Wisconsin needs more tech workers 3To be a player in the "Knowledge Economy," Wisconsin needs more tech workers 4Genomic Analysis of Formalin-Fixed Paraffin Embedded (FFPE) Tissues through the use of Whole Genome Amplification (WGA) 2Genomic Analysis of Formalin-Fixed Paraffin Embedded (FFPE) Tissues through the use of Whole Genome Amplification (WGA) 3Genomic Analysis of Formalin-Fixed Paraffin Embedded (FFPE) Tissues through the use of Whole Genome Amplification (WGA) 4Genomic Analysis of Formalin-Fixed Paraffin Embedded (FFPE) Tissues through the use of Whole Genome Amplification (WGA) 5Genomic Analysis of Formalin-Fixed Paraffin Embedded (FFPE) Tissues through the use of Whole Genome Amplification (WGA) 6Genomic Analysis of Formalin-Fixed Paraffin Embedded (FFPE) Tissues through the use of Whole Genome Amplification (WGA) 7140-Fold Increase of Protein Achieved in Pichia Fermentation 2
(Date:9/30/2014)... German . , ... situations such as exposure to predators. Researchers from the ... long-term study on different populations of great tits that ... temperature. High metabolic rates and low temperatures were associated ... were more likely to approach potential predators. , The ...
(Date:9/30/2014)... suite of perilous threats in today,s ocean. From ... change, fragile coral ecosystems are disappearing at unprecedented ... species of corals surrounding the island of Moorea ... their tropical environment: coral guard-crabs. New research from ... Station scientist Seabird McKeon and the museum,s predoctoral ...
(Date:9/30/2014)... KONG , Sept. 30, 2014 Winners of ... Economist Events, Innovation Summit scheduled to take place at the JW ... the summit, the award winners will share their experiences and the ... who have made a proven innovation over the past decade, will ... the night before the summit. It will be the first ...
Breaking Biology News(10 mins):Risky metabolism 2Smithsonian scientists discover coral's best defender against an army of sea stars 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 3Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 4Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 5Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 6Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 7
... new evidence that certain high blood pressure drugs may be ... of vision loss in people with diabetes. The study, the ... to new ways to prevent or treat the sight-threatening disease, ... Proteome Research , a monthly publication. Edward Feener ...
... Los Angeles, CA Current research suggests that nitric oxide ... The related report by Mittal et al, "Inhibition of ... enhancing phagocytosis of Escherichia coli K1 in neonatal ... American Journal of Pathology . Bacterial meningitis, or ...
... non-neurotoxic treatment for head lice has been found to have an ... be safe in humans from six months of age and up. ... Pediatric Dermatology . Benzyl Alcohol Lotion 5% (known as ... been attempted by treating with household items such as mayonnaise, olive ...
Cached Biology News:Treating neonatal meningitis -- is nitric oxide a foe or a friend to bacteria? 2Study shows that suffocating head lice works in new treatment 2
BD Falcon Center-well 60 mm In Vitro Fertilization (IVF) Dish, nonembryotoxic, noncytotoxic, tissue-culture treated polystyrene. (20/sp, 500/ca) Packaging: 20 / sleeve, 500 / case ...
... Collagen I 60 mm Culture Dishes BD ... treated polystyrene with a uniform application of rat ... Collagen I ,Surface : ECM/attachment ... ,Dim nominal : 60 mm x ...
...
The piston kit includes 2 pistons to service one F10 pump of a BioLogic DuoFlow workstation....
Biology Products: